Immunocore Holdings Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Immunocore Holdings plc (IMCR) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.460.440.400.320.18
Short-Term Investments0.360.000.000.000.00
Cash & Short-Term Investments0.820.440.400.320.18
Accounts Receivable0.060.050.060.010.02
Inventory0.010.000.000.000.00
Other Current Assets0.010.010.010.010.01
Total Current Assets0.930.530.470.350.21
Non-Current Assets
Property, Plant & Equipment (Net)0.050.040.040.040.05
Other Non-Current Assets0.020.010.010.000.01
Total Non-Current Assets0.080.070.040.050.04
Total Assets1.010.600.530.410.27
Current Liabilities
Accounts Payable0.030.020.010.010.01
Short-Term Debt0.000.000.000.000.00
Accrued Liabilities0.170.110.070.040.03
Deferred Revenue0.000.000.010.030.04
Other Current Liabilities0.000.000.000.000.00
Total Current Liabilities0.210.140.100.080.08
Non-Current Liabilities
Long-Term Debt0.390.050.050.050.05
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.440.090.070.090.09
Total Liabilities0.650.230.190.180.19
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-0.80-0.74-0.69-0.65-0.48
Accumulated Other Comprehensive Income-0.03-0.04-0.050.520.55
Additional Paid-in Capital1.191.150.120.290.00
Shares Outstanding0.050.050.050.040.00
Total Stockholders' Equity0.360.370.340.230.08
Total Liabilities & Equity1.010.600.440.410.20